These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28383419)

  • 1. Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging.
    Sun J; Song H; Yang Y; Zhang K; Gao X; Li X; Ni L; Lin P; Niu C
    Medicine (Baltimore); 2017 Apr; 96(14):e6534. PubMed ID: 28383419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
    Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W
    PLoS One; 2010 Jul; 5(7):e11625. PubMed ID: 20652023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
    Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
    Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; McLean MA; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
    J Neurol; 2006 Feb; 253(2):224-30. PubMed ID: 16307201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
    Suhy J; Rooney WD; Goodkin DE; Capizzano AA; Soher BJ; Maudsley AA; Waubant E; Andersson PB; Weiner MW
    Mult Scler; 2000 Jun; 6(3):148-55. PubMed ID: 10871825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.
    Kirov II; Liu S; Tal A; Wu WE; Davitz MS; Babb JS; Rusinek H; Herbert J; Gonen O
    Hum Brain Mapp; 2017 Aug; 38(8):4047-4063. PubMed ID: 28523763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.
    Chard DT; Griffin CM; McLean MA; Kapeller P; Kapoor R; Thompson AJ; Miller DH
    Brain; 2002 Oct; 125(Pt 10):2342-52. PubMed ID: 12244090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis: a HMRS study.
    Casanova B; Martínez-Bisbal MC; Valero C; Celda B; Martí-Bonmatí L; Pascual A; Landente L; Coret F
    J Neurol; 2003 Jan; 250(1):22-8. PubMed ID: 12527988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
    Gadea M; Martínez-Bisbal MC; Marti-Bonmatí L; Espert R; Casanova B; Coret F; Celda B
    Brain; 2004 Jan; 127(Pt 1):89-98. PubMed ID: 14506072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study.
    Kapeller P; McLean MA; Griffin CM; Chard D; Parker GJ; Barker GJ; Thompson AJ; Miller DH
    J Neurol; 2001 Feb; 248(2):131-8. PubMed ID: 11284131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.
    Yetkin MF; Mirza M; Dönmez H
    Medicine (Baltimore); 2016 Sep; 95(36):e4782. PubMed ID: 27603381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
    Sijens PE; Mostert JP; Oudkerk M; De Keyser J
    Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
    Hannoun S; Bagory M; Durand-Dubief F; Ibarrola D; Comte JC; Confavreux C; Cotton F; Sappey-Marinier D
    PLoS One; 2012; 7(3):e32525. PubMed ID: 22479330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue.
    Kantorová E; Poláček H; Bittšanský M; Baranovičová E; Hnilicová P; Čierny D; Sivák Š; Nosáľ V; Zeleňák K; Kurča E
    Neurol Res; 2017 Apr; 39(4):323-330. PubMed ID: 28191860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue.
    Tackley G; Kong Y; Minne R; Messina S; Winkler A; Cavey A; Everett R; DeLuca GC; Weir A; Craner M; Tracey I; Palace J; Stagg CJ; Emir U
    Neuroimage; 2021 Sep; 238():118225. PubMed ID: 34062267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
    Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.
    Schocke MF; Berger T; Felber SR; Wolf C; Deisenhammer F; Kremser C; Seppi K; Aichner FT
    Neuroimage; 2003 Oct; 20(2):1253-63. PubMed ID: 14568494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.